CDT stock analysis: momentum, squeeze and dilution
MonScreener's historical stock analysis for CDT, using the latest stored scan snapshot. Review the recorded momentum score, float and volume data, short-pressure fields and SEC dilution context that were available on that date.
- Snapshot price
- $0.1600
- Snapshot session change
- -14.62%
- Sector
- Healthcare
- Market capitalization
- 2.21M
- Session volume
- 12,403,637
- Relative volume
- 111.54×
- Float
- 5.01M
- MonScreener score
- 33/100 · grade D
- Risk band
- High
- Short float
- 0.84%
- Cost to borrow
- 216.29%
- Days to cover
- 0.02
- Dilution risk
- HIGH
- Registered offering capacity vs. float value
- 315.40%
- SEC filing warning
- Present
- Snapshot date
- 2026-09-18
- Data source
- historical snapshot
Historical scan snapshot timestamp: 2026-09-18. Snapshot values can be stale or incomplete; the interactive stock analysis loads separately.
Momentum score and grade
The stored snapshot scored CDT at 33/100 with a D grade. The score combines available momentum, float, volume, catalyst, squeeze and dilution inputs. It is a research ranking, not a recommendation or forecast.
Short-squeeze and borrow context
Available fields in this snapshot include short float 0.84%, cost to borrow 216.29%, 0.02 days to cover. These values can change quickly and may come from delayed or limited provider coverage. Compare them with float, liquidity, a verifiable catalyst and current broker data. Learn how MonScreener evaluates squeeze candidates.
SEC dilution context
The stored snapshot included an SEC filing warning. Registered offering capacity was estimated at 315.40% of float market value. Automated filing signals can miss or misread terms, so confirm the latest primary filing before acting. Read the SEC dilution research guide.
Explore: Stock Screener · Prediction Track Record · MonScreener home